APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rosiglitazone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rosiglitazone Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchRosiglitazone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rosiglitazone Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Rosiglitazone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rosiglitazone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rosiglitazone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rosiglitazone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rosiglitazone include Wanma Pharma, Taiji Group, Jingxin Pharma, Huanghe Pharma, Shengjitang Pharma, GSK, Hengrui Pharma and STADA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rosiglitazone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rosiglitazone market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rosiglitazone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rosiglitazone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rosiglitazone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rosiglitazone Market by Company

Wanma Pharma

Taiji Group

Jingxin Pharma

Huanghe Pharma

Shengjitang Pharma

GSK

Hengrui Pharma

STADA

Rosiglitazone Segment by Type

Rosiglitazone Hydrochloride Tablets

Rosiglitazone Maleate Tablets

Rosiglitazone Tablets

Others

Rosiglitazone Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Rosiglitazone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosiglitazone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rosiglitazone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosiglitazone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rosiglitazone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rosiglitazone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rosiglitazone Hydrochloride Tablets Table 2. Major Company of Rosiglitazone Maleate Tablets Table 3. Major Company of Rosiglitazone Tablets Table 4. Major Company of Others Table 5. Global Rosiglitazone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Rosiglitazone Sales by Type (2021-2026) & (kg) Table 7. Global Rosiglitazone Sales Market Share in Volume by Type (2021-2026) Table 8. Global Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 9. Global Rosiglitazone Sales Market Share in Value by Type (2021-2026) Table 10. Global Rosiglitazone Price by Type (2021-2026) & (US$/kg) Table 11. Global Rosiglitazone Sales by Type (2027-2032) & (kg) Table 12. Global Rosiglitazone Sales Market Share in Volume by Type (2027-2032) Table 13. Global Rosiglitazone Sales by Type (2027-2032) & (US$ Million) Table 14. Global Rosiglitazone Sales Market Share in Value by Type (2027-2032) Table 15. Global Rosiglitazone Price by Type (2027-2032) & (US$/kg) Table 16. North America Rosiglitazone Sales by Type (2021-2026) & (kg) Table 17. North America Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Rosiglitazone Sales by Type (2021-2026) & (kg) Table 19. Europe Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Rosiglitazone Sales by Type (2021-2026) & (kg) Table 21. Asia-Pacific Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Rosiglitazone Sales by Type (2021-2026) & (kg) Table 23. Latin America Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Rosiglitazone Sales by Type (2021-2026) & (kg) Table 25. Middle East and Africa Rosiglitazone Sales by Type (2021-2026) & (US$ Million) Table 26. Rosiglitazone Industry Trends Table 27. Rosiglitazone Industry Drivers Table 28. Rosiglitazone Industry Opportunities and Challenges Table 29. Rosiglitazone Industry Restraints Table 30. Global Rosiglitazone Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Rosiglitazone Revenue Market Share by Company (2021-2026) Table 32. Global Rosiglitazone Sales by Company (2021-2026) & (kg) Table 33. Global Rosiglitazone Sales Share by Company (2021-2026) Table 34. Global Rosiglitazone Market Price by Company (2021-2026) & (US$/kg) Table 35. Global Rosiglitazone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Rosiglitazone Major Company Production Sites and Headquarters Table 37. Global Rosiglitazone Company, Product Type & Application Table 38. Global Rosiglitazone Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Rosiglitazone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Rosiglitazone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Rosiglitazone Sales by Region (2021-2026) & (kg) Table 43. Global Rosiglitazone Sales Market Share in Volume by Region (2021-2026) Table 44. Global Rosiglitazone Sales by Region (2021-2026) & (US$ Million) Table 45. Global Rosiglitazone Sales Market Share in Value by Region (2021-2026) Table 46. Global Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 47. Global Rosiglitazone Sales by Region (2027-2032) & (kg) Table 48. Global Rosiglitazone Sales Market Share in Volume by Region (2027-2032) Table 49. Global Rosiglitazone Sales by Region (2027-2032) & (US$ Million) Table 50. Global Rosiglitazone Sales Market Share in Value by Region (2027-2032) Table 51. Global Rosiglitazone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 52. Global Rosiglitazone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Rosiglitazone Sales by Application (2021-2026) & (kg) Table 54. Global Rosiglitazone Sales Market Share in Volume by Application (2021-2026) Table 55. Global Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 56. Global Rosiglitazone Sales Market Share in Value by Application (2021-2026) Table 57. Global Rosiglitazone Price by Application (2021-2026) & (US$/kg) Table 58. Global Rosiglitazone Sales by Application (2027-2032) & (kg) Table 59. Global Rosiglitazone Sales Market Share in Volume by Application (2027-2032) Table 60. Global Rosiglitazone Sales by Application (2027-2032) & (US$ Million) Table 61. Global Rosiglitazone Sales Market Share in Value by Application (2027-2032) Table 62. Global Rosiglitazone Price by Application (2027-2032) & (US$/kg) Table 63. North America Rosiglitazone Sales by Application (2021-2026) & (kg) Table 64. North America Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Rosiglitazone Sales by Application (2021-2026) & (kg) Table 66. Europe Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Rosiglitazone Sales by Application (2021-2026) & (kg) Table 68. Asia-Pacific Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Rosiglitazone Sales by Application (2021-2026) & (kg) Table 70. Latin America Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Rosiglitazone Sales by Application (2021-2026) & (kg) Table 72. Middle East and Africa Rosiglitazone Sales by Application (2021-2026) & (US$ Million) Table 73. Wanma Pharma Company Information Table 74. Wanma Pharma Business Overview Table 75. Wanma Pharma Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Wanma Pharma Rosiglitazone Product Portfolio Table 77. Wanma Pharma Recent Development Table 78. Taiji Group Company Information Table 79. Taiji Group Business Overview Table 80. Taiji Group Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Taiji Group Rosiglitazone Product Portfolio Table 82. Taiji Group Recent Development Table 83. Jingxin Pharma Company Information Table 84. Jingxin Pharma Business Overview Table 85. Jingxin Pharma Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Jingxin Pharma Rosiglitazone Product Portfolio Table 87. Jingxin Pharma Recent Development Table 88. Huanghe Pharma Company Information Table 89. Huanghe Pharma Business Overview Table 90. Huanghe Pharma Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Huanghe Pharma Rosiglitazone Product Portfolio Table 92. Huanghe Pharma Recent Development Table 93. Shengjitang Pharma Company Information Table 94. Shengjitang Pharma Business Overview Table 95. Shengjitang Pharma Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Shengjitang Pharma Rosiglitazone Product Portfolio Table 97. Shengjitang Pharma Recent Development Table 98. GSK Company Information Table 99. GSK Business Overview Table 100. GSK Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 101. GSK Rosiglitazone Product Portfolio Table 102. GSK Recent Development Table 103. Hengrui Pharma Company Information Table 104. Hengrui Pharma Business Overview Table 105. Hengrui Pharma Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 106. Hengrui Pharma Rosiglitazone Product Portfolio Table 107. Hengrui Pharma Recent Development Table 108. STADA Company Information Table 109. STADA Business Overview Table 110. STADA Rosiglitazone Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 111. STADA Rosiglitazone Product Portfolio Table 112. STADA Recent Development Table 113. North America Rosiglitazone Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 114. North America Rosiglitazone Sales by Country (2021-2026) & (kg) Table 115. North America Rosiglitazone Sales Market Share by Country (2021-2026) Table 116. North America Rosiglitazone Sales Forecast by Country (2027-2032) & (kg) Table 117. North America Rosiglitazone Sales Market Share Forecast by Country (2027-2032) Table 118. North America Rosiglitazone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Rosiglitazone Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Rosiglitazone Market Share by Country (2021-2026) Table 121. North America Rosiglitazone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Rosiglitazone Market Share Forecast by Country (2027-2032) Table 123. Europe Rosiglitazone Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 124. Europe Rosiglitazone Sales by Country (2021-2026) & (kg) Table 125. Europe Rosiglitazone Sales Market Share by Country (2021-2026) Table 126. Europe Rosiglitazone Sales Forecast by Country (2027-2032) & (kg) Table 127. Europe Rosiglitazone Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Rosiglitazone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Rosiglitazone Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Rosiglitazone Market Share by Country (2021-2026) Table 131. Europe Rosiglitazone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Rosiglitazone Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Rosiglitazone Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Rosiglitazone Sales by Country (2021-2026) & (kg) Table 135. Asia-Pacific Rosiglitazone Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Rosiglitazone Sales Forecast by Country (2027-2032) & (kg) Table 137. Asia-Pacific Rosiglitazone Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Rosiglitazone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Rosiglitazone Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Rosiglitazone Market Share by Country (2021-2026) Table 141. Asia-Pacific Rosiglitazone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Rosiglitazone Market Share Forecast by Country (2027-2032) Table 143. Latin America Rosiglitazone Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 144. Latin America Rosiglitazone Sales by Country (2021-2026) & (kg) Table 145. Latin America Rosiglitazone Sales Market Share by Country (2021-2026) Table 146. Latin America Rosiglitazone Sales Forecast by Country (2027-2032) & (kg) Table 147. Latin America Rosiglitazone Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Rosiglitazone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Rosiglitazone Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Rosiglitazone Market Share by Country (2021-2026) Table 151. Latin America Rosiglitazone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Rosiglitazone Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Rosiglitazone Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Rosiglitazone Sales by Country (2021-2026) & (kg) Table 155. Middle East and Africa Rosiglitazone Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Rosiglitazone Sales Forecast by Country (2027-2032) & (kg) Table 157. Middle East and Africa Rosiglitazone Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Rosiglitazone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Rosiglitazone Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Rosiglitazone Market Share by Country (2021-2026) Table 161. Middle East and Africa Rosiglitazone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Rosiglitazone Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Rosiglitazone Distributors List Table 166. Rosiglitazone Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Rosiglitazone Image Figure 2. Global Rosiglitazone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rosiglitazone Market Size (2021-2032) & (US$ Million) Figure 4. Global Rosiglitazone Sales (2021-2032) & (kg) Figure 5. Rosiglitazone Hydrochloride Tablets Image Figure 6. Global Rosiglitazone Hydrochloride Tablets Sales YoY Growth (2021-2032) & (kg) Figure 7. Rosiglitazone Maleate Tablets Image Figure 8. Global Rosiglitazone Maleate Tablets Sales YoY Growth (2021-2032) & (kg) Figure 9. Rosiglitazone Tablets Image Figure 10. Global Rosiglitazone Tablets Sales YoY Growth (2021-2032) & (kg) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (kg) Figure 13. Global Rosiglitazone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Rosiglitazone Market Share by Type 2025 VS 2032 Figure 15. North America Rosiglitazone Sales Market Share in Volume by Type in 2025 Figure 16. North America Rosiglitazone Sales Market Share in Value by Type in 2025 Figure 17. Europe Rosiglitazone Sales Market Share in Volume by Type in 2025 Figure 18. Europe Rosiglitazone Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Rosiglitazone Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Rosiglitazone Sales Market Share in Value by Type in 2025 Figure 21. Latin America Rosiglitazone Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Rosiglitazone Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Rosiglitazone Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Rosiglitazone Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Rosiglitazone Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 33. Global Rosiglitazone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Rosiglitazone Market Share by Application 2025 VS 2032 Figure 35. North America Rosiglitazone Sales Market Share in Volume by Application in 2025 Figure 36. North America Rosiglitazone Sales Market Share in Value by Application in 2025 Figure 37. Europe Rosiglitazone Sales Market Share in Volume by Application in 2025 Figure 38. Europe Rosiglitazone Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Rosiglitazone Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Rosiglitazone Sales Market Share in Value by Application in 2025 Figure 41. Latin America Rosiglitazone Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Rosiglitazone Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Rosiglitazone Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Rosiglitazone Sales Market Share in Value by Application in 2025 Figure 45. North America Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. North America Rosiglitazone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Rosiglitazone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Europe Rosiglitazone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Rosiglitazone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Asia-Pacific Rosiglitazone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Rosiglitazone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Latin America Rosiglitazone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Rosiglitazone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Rosiglitazone Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 62. Middle East and Africa Rosiglitazone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Rosiglitazone Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Rosiglitazone Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Rosiglitazone Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Rosiglitazone Hydrochloride Tablets
  • Rosiglitazone Maleate Tablets
  • Rosiglitazone Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Wanma Pharma
  • Taiji Group
  • Jingxin Pharma
  • Huanghe Pharma
  • Shengjitang Pharma
  • GSK
  • Hengrui Pharma
  • STADA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rosiglitazone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rosiglitazone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rosiglitazone Market by Type
  6. 1.3.1 Rosiglitazone Hydrochloride Tablets
  7. 1.3.2 Rosiglitazone Maleate Tablets
  8. 1.3.3 Rosiglitazone Tablets
  9. 1.3.4 Others
  10. 1.4 Global Rosiglitazone Market Size by Type
  11. 1.4.1 Global Rosiglitazone Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Rosiglitazone Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Rosiglitazone Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Rosiglitazone Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Rosiglitazone Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Rosiglitazone Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Rosiglitazone Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Rosiglitazone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rosiglitazone Industry Trends
  2. 2.2 Rosiglitazone Industry Drivers
  3. 2.3 Rosiglitazone Industry Opportunities and Challenges
  4. 2.4 Rosiglitazone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rosiglitazone Revenue (2021-2026)
  2. 3.2 Global Top Players by Rosiglitazone Sales (2021-2026)
  3. 3.3 Global Top Players by Rosiglitazone Price (2021-2026)
  4. 3.4 Global Rosiglitazone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rosiglitazone Major Company Production Sites & Headquarters
  6. 3.6 Global Rosiglitazone Company, Product Type & Application
  7. 3.7 Global Rosiglitazone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rosiglitazone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rosiglitazone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rosiglitazone Tier 1, Tier 2, and Tier 3
4 Rosiglitazone Regional Status and Outlook
  1. 4.1 Global Rosiglitazone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rosiglitazone Historic Market Size by Region
  3. 4.2.1 Global Rosiglitazone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rosiglitazone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rosiglitazone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rosiglitazone Forecasted Market Size by Region
  7. 4.3.1 Global Rosiglitazone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rosiglitazone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rosiglitazone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rosiglitazone by Application
  1. 5.1 Rosiglitazone Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Rosiglitazone Market Size by Application
  6. 5.2.1 Global Rosiglitazone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rosiglitazone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rosiglitazone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rosiglitazone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rosiglitazone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rosiglitazone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rosiglitazone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rosiglitazone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wanma Pharma
  2. 6.1.1 Wanma Pharma Company Information
  3. 6.1.2 Wanma Pharma Business Overview
  4. 6.1.3 Wanma Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wanma Pharma Rosiglitazone Product Portfolio
  6. 6.1.5 Wanma Pharma Recent Developments
  7. 6.2 Taiji Group
  8. 6.2.1 Taiji Group Company Information
  9. 6.2.2 Taiji Group Business Overview
  10. 6.2.3 Taiji Group Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taiji Group Rosiglitazone Product Portfolio
  12. 6.2.5 Taiji Group Recent Developments
  13. 6.3 Jingxin Pharma
  14. 6.3.1 Jingxin Pharma Company Information
  15. 6.3.2 Jingxin Pharma Business Overview
  16. 6.3.3 Jingxin Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jingxin Pharma Rosiglitazone Product Portfolio
  18. 6.3.5 Jingxin Pharma Recent Developments
  19. 6.4 Huanghe Pharma
  20. 6.4.1 Huanghe Pharma Company Information
  21. 6.4.2 Huanghe Pharma Business Overview
  22. 6.4.3 Huanghe Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Huanghe Pharma Rosiglitazone Product Portfolio
  24. 6.4.5 Huanghe Pharma Recent Developments
  25. 6.5 Shengjitang Pharma
  26. 6.5.1 Shengjitang Pharma Company Information
  27. 6.5.2 Shengjitang Pharma Business Overview
  28. 6.5.3 Shengjitang Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shengjitang Pharma Rosiglitazone Product Portfolio
  30. 6.5.5 Shengjitang Pharma Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Rosiglitazone Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Hengrui Pharma
  38. 6.7.1 Hengrui Pharma Company Information
  39. 6.7.2 Hengrui Pharma Business Overview
  40. 6.7.3 Hengrui Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hengrui Pharma Rosiglitazone Product Portfolio
  42. 6.7.5 Hengrui Pharma Recent Developments
  43. 6.8 STADA
  44. 6.8.1 STADA Company Information
  45. 6.8.2 STADA Business Overview
  46. 6.8.3 STADA Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 STADA Rosiglitazone Product Portfolio
  48. 6.8.5 STADA Recent Developments
7 North America by Country
  1. 7.1 North America Rosiglitazone Sales by Country
  2. 7.1.1 North America Rosiglitazone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rosiglitazone Sales by Country (2021-2026)
  4. 7.1.3 North America Rosiglitazone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rosiglitazone Market Size by Country
  6. 7.2.1 North America Rosiglitazone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rosiglitazone Market Size by Country (2021-2026)
  8. 7.2.3 North America Rosiglitazone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rosiglitazone Sales by Country
  2. 8.1.1 Europe Rosiglitazone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rosiglitazone Sales by Country (2021-2026)
  4. 8.1.3 Europe Rosiglitazone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rosiglitazone Market Size by Country
  6. 8.2.1 Europe Rosiglitazone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rosiglitazone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rosiglitazone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rosiglitazone Sales by Country
  2. 9.1.1 Asia-Pacific Rosiglitazone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rosiglitazone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rosiglitazone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rosiglitazone Market Size by Country
  6. 9.2.1 Asia-Pacific Rosiglitazone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rosiglitazone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rosiglitazone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rosiglitazone Sales by Country
  2. 10.1.1 South America Rosiglitazone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rosiglitazone Sales by Country (2021-2026)
  4. 10.1.3 South America Rosiglitazone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rosiglitazone Market Size by Country
  6. 10.2.1 South America Rosiglitazone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rosiglitazone Market Size by Country (2021-2026)
  8. 10.2.3 South America Rosiglitazone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rosiglitazone Sales by Country
  2. 11.1.1 Middle East and Africa Rosiglitazone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rosiglitazone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rosiglitazone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rosiglitazone Market Size by Country
  6. 11.2.1 Middle East and Africa Rosiglitazone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rosiglitazone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rosiglitazone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rosiglitazone Value Chain Analysis
  2. 12.1.1 Rosiglitazone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rosiglitazone Production Mode & Process
  7. 12.2 Rosiglitazone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rosiglitazone Distributors
  10. 12.2.3 Rosiglitazone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst